| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LGVN | Longeveron Inc. | Director | $43.6K | -$2.59K | -5.6% | Aug 11, 2025 |
| PCSA | Processa Pharmaceuticals, Inc. | Director | Oct 1, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|